Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/113927
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorAu, Hiu Yeung-
dc.creatorChan, Yin Yan-
dc.creatorHu, Xinrui-
dc.creatorSun, Jiayan-
dc.creatorZhu, Siya-
dc.creatorChapagain, Swastika-
dc.creatorLi, Xiangyi-
dc.creatorLiu, Chenyi-
dc.creatorShaikh, Muhammad Waris-
dc.creatorLi, Pinxuan-
dc.identifier.urihttps://ows.lib.polyu.edu.hk/s/ows/item/4108-
dc.language.isoEnglish-
dc.rightsAll rights reserved-
dc.subjectCancer Biology-
dc.subjectSynthetic Biology-
dc.subjectProtein Engineering and Biotechnology-
dc.subjectPharmacology and Drug Resistance-
dc.subjectTranslational Medicine and Human Practices-
dc.titlePanoPOLY: Innovating Cancer Treatment-
dc.typeFeature Story-
dc.typeOWS-
dcterms.abstractPanoPOLY is a student-led initiative dedicated to advancing pancreatic cancer treatment, one of the most challenging and deadly cancers. Through the iGEM competition, their team developed a novel dual-targeting nanobody designed to overcome gemcitabine resistance in pancreatic cancer. By combining synthetic biology, innovative protein engineering, and community outreach, They aim to improve patient survival rates and bring new hope to affected families. Their project earned a Gold Medal, ranked among the Top 10 undergraduate teams worldwide, and was nominated for Best Oncology Project and Best New Composite Part at iGEM 2024, recognizing both their scientific and societal impact.-
dcterms.accessRightsopen access-
dcterms.issued2025-06-
dcterms.LCSHPancreas -- Cancer -- Research-
dcterms.LCSHDrug Resistance, Neoplasm-
dcterms.educationalLevelUndergraduate-
Appears in Collections:Outstanding Work by Students
Access
View full-text via https://ows.lib.polyu.edu.hk/s/ows/item/4108
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.